Acrizanib
| CAS No. | 1229453-99-9 | Cat. No. | BCP36110 |
| Name | Acrizanib | ||
| Synonyms | LHA510; LHA 510; LHA-510; | ||
| Formula | C20H18F3N7O2 | M. Wt | 445.41 |
| Description | Acrizanib, also known as LHA510, is a potent and selective angiogenesis inhibitor and VEGFR‑2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular Degeneration. | ||
| Pathways | Angiogenesis/Protein Tyrosine Kinase | ||
| Targets | VEGFR | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.